✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Moderna Inc

Common Name
Moderna
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
4,700
Ticker
MRNA
Exchange
Nasdaq
Description
Moderna, Inc. is a biotechnology company specializing in the development of transformative medicines using messenger ribonucleic acid (mRNA) technology. Its primary focus lies in creating innovative t...

Moderna's GHG Emissions Data Preview

In 2025, Moderna completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Moderna has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022-2019
Total Scope 1
10,463a
13,180a
11,353a
Total Scope 2
Market-Based
284a
51a
431a
Location-Based
21,283a
17,705a
11,506a
Total Scope 3
N/A
714,380a
1,341,825a
Total Scope 1 Revenue Intensity (tCO2e/$M)
5.4438a
4.12a
1.6809a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=MRNA&reporting_period=2025"

Verified Sources Behind Moderna’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Moderna's Impact Report 2025

Insights into Moderna's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Moderna amounted to 31,746 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Moderna increased by 2.79%, suggesting that the company faced challenges in reducing its emissions from its core operations.a

Moderna's Scope 1 Emissions Over Time

2021202220232024202503.5 k7 k10.5 k14 ktCO2e+26%-2%+16%-21%
  • Total Scope 1
  • Year-over-Year Change

What are Moderna's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Moderna were 10,463 metric tons of CO₂ equivalent (tCO₂e).a

Has Moderna reduced its Scope 1 emissions over time?

Since 2021, Moderna's Scope 1 emissions have increased by 14.46%, reflecting a rising long-term trend in Scope 1 emissions over time.a

Compared to the previous year (2024), Moderna's Scope 1 emissions decreased by 20.61%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Moderna's Scope 2 emissions?

In 2025, Moderna reported Scope 2 greenhouse gas (GHG) emissions of 284 tCO₂e using the market-based method and 21,283 tCO₂e using the location-based method.a

Has Moderna reduced its Scope 2 emissions over time?

Since 2021, Moderna's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have increased by 162.14%, reflecting a rising long-term trend in Scope 2 emissions over time.a

Compared to the previous year (2024), Moderna's Scope 2 emissions (Location-Based) rose by 20.21% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya

What methodology does Moderna use for Scope 2 reporting?

In 2025, Moderna reported its Scope 2 emissions using the market-based method and using the location-based method.a

Moderna's Scope 2 Emissions Over Time

2021202220232024202505.5 k11 k16.5 k22 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Moderna’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Moderna reported Scope 1 greenhouse gas (GHG) emissions of 10,463 tCO₂e and total revenues of USD 1,922 millions. This translates into an emissions intensity of 5.44 tCO₂e per millions USD.a

Moderna's Scope 1 Emissions Intensity Compared to Peers

2501,00020,000200,000Scope 1 Emissions (tCO2e)201001,0005,00050,000Revenues (Millions of USD)Samsung BiologicsYear: 2024Scope 1: 71,972 tCO2eRevenue: $M 3,099Scope 1 Intensity: 23.22 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,559Scope 1 Intensity: 14.99 tCO2e/$MInnovent BiologicsYear: 2025Scope 1: 7,803 tCO2eRevenue: $M 1,863Scope 1 Intensity: 4.19 tCO2e/$MBiontechYear: 2025Scope 1: 2,209 tCO2eRevenue: $M 3,374Scope 1 Intensity: 0.65 tCO2e/$MCelltrionYear: 2024Scope 1: 27,147 tCO2eRevenue: $M 2,424Scope 1 Intensity: 11.20 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 260Scope 1 Intensity: 11.10 tCO2e/$MRecursion PharmaceuticalsYear: 2023Scope 1: 854 tCO2eRevenue: $M 45Scope 1 Intensity: 19.16 tCO2e/$MCatalyst PharmaceuticalsYear: 2024Scope 1: 4 tCO2eRevenue: $M 493Scope 1 Intensity: 0.01 tCO2e/$MCytokineticsYear: 2025Scope 1: 294 tCO2eRevenue: $M 88Scope 1 Intensity: 3.34 tCO2e/$MIonis PharmaceuticalsYear: 2025Scope 1: 2,615 tCO2eRevenue: $M 944Scope 1 Intensity: 2.77 tCO2e/$MRegeneron PharmaceuticalsYear: 2025Scope 1: 89,990 tCO2eRevenue: $M 14,343Scope 1 Intensity: 6.27 tCO2e/$MVertex PharmaceuticalsYear: 2025Scope 1: 12,296 tCO2eRevenue: $M 12,001Scope 1 Intensity: 1.02 tCO2e/$MInsmedYear: 2025Scope 1: 2,622 tCO2eRevenue: $M 606Scope 1 Intensity: 4.32 tCO2e/$MIncyteYear: 2025Scope 1: 8,872 tCO2eRevenue: $M 5,141Scope 1 Intensity: 1.73 tCO2e/$MAlnylam PharmaceuticalsYear: 2025Scope 1: 6,785 tCO2eRevenue: $M 3,714Scope 1 Intensity: 1.83 tCO2e/$MFortrea HoldingsYear: 2025Scope 1: 1,418 tCO2eRevenue: $M 2,723Scope 1 Intensity: 0.52 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MHalozyme TherapeuticsYear: 2025Scope 1: 1,104 tCO2eRevenue: $M 1,397Scope 1 Intensity: 0.79 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MModernaYear: 2025Scope 1: 10,463 tCO2eRevenue: $M 1,922Scope 1 Intensity: 5.44 tCO2e/$M

How does Moderna's GHG emissions intensity compare to its peers?

In 2025, Moderna reported a Scope 1 emissions intensity of 5.44 tCO₂e per millions USD. Compared to the peer group median of 2.77, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Moderna rank on GHG emissions intensity within its industry?

In 2025, Moderna ranked 15 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Moderna is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Moderna's GHG Emissions Dataset?
Start 30-Day Free Trial